Abstract
Mast cells (MCs) are powerful immune cells that mature in the peripheral tissues from bone marrow (BM)-derived mast cell progenitors (MCp). Accumulation of MCs in lung compartments where they are normally absent is thought to enhance symptoms in asthma. The enrichment of lung MCs is also observed in mice subjected to models of allergic airway inflammation. However, whether other types of lung inflammation trigger increased number of MCp, which give rise to MCs, is unknown. Here, mouse-adapted H1N1 influenza A was used as a model of respiratory virus infection. Intranasal administration of the virus induced expression of VCAM-1 on the lung vascular endothelium and an extensive increase in integrin β7hi lung MCp. Experiments were performed to distinguish whether the influenza-induced increase in the number of lung MCp was triggered mainly by recruitment or in situ cell proliferation. A similar proportion of lung MCp from influenza-infected and PBS control mice were found to be in a proliferative state. Furthermore, BM chimeric mice were used in which the possibility of influenza-induced in situ cell proliferation of host MCp was prevented. Influenza infection in the chimeric mice induced a similar number of lung MCp as in normal mice. These experiments demonstrated that recruitment of MCp to the lung is the major mechanism behind the influenza-induced increase in lung MCp. Fifteen days post-infection, the influenza infection had elicited an immature MC population expressing intermediate levels of integrin β7, which was absent in controls. At the same time point, an increased number of toluidine blue+ MCs was detected in the upper central airways. When the inflammation was resolved, the MCs that accumulated in the lung upon influenza infection were gradually lost. In summary, our study reveals that influenza infection induces a transient accumulation of lung MCs through the recruitment and maturation of MCp. We speculate that temporary augmented numbers of lung MCs are a cause behind virus-induced exacerbations of MC-related lung diseases such as asthma.
Highlights
Mast cells (MCs) develop from committed mast cell progenitors (MCp) in the bone marrow (BM), which enter tissues via the blood and mature into MCs [1]
Earlier studies have shown that MCp are recruited to the lung and give rise to MCs in mouse models of allergic airway inflammation [8, 9, 12, 13], the present study demonstrates for the first time that MCp are recruited to the lung during a completely different type of inflammatory response, i.e., influenza infection
The H1N1 influenza A virus triggered a tremendous increase in highly proliferating lung MCp, which was significant already
Summary
Mast cells (MCs) develop from committed mast cell progenitors (MCp) in the bone marrow (BM), which enter tissues via the blood and mature into MCs [1]. These cells play a crucial role in life-threatening allergic reactions such as in anaphylaxis and asthma attacks. MCs accumulate in the airway smooth muscles and lung epithelium [2, 3]. Respiratory virus infections are the major cause of exacerbations of asthma [4]. The exacerbations lead to suffering for the patients, and in worse case, they can have a fatal outcome
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.